The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia


Journal

Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758

Informations de publication

Date de publication:
18 04 2019
Historique:
entrez: 20 3 2019
pubmed: 20 3 2019
medline: 12 9 2019
Statut: epublish

Résumé

The distribution of Mediterranean fever (MEFV) gene mutations in Turkish familial Mediterranean fever (FMF) patients varies according to geographic area of Turkey. There is a need for highly representative data for Turkish FMF patients. The aim of our study was to investigate the distribution of the common MEFV mutations in Turkish FMF patients in a nationwide, multicenter study. Data of the 2246 FMF patients, from 15 adult rheumatology clinics located in different parts of the country, were evaluated retrospectively. The following mutations have been tested in all patients: M694V, M680I, M694I, V726A, and E148Q. There were 1719 FMF patients with available genetic testing. According to the genotyping, homozygous M694V, present in 413 patients (24%), was the most common mutation . One hundred and fifty-four (9%) of patients had no detectable mutations. Allele frequencies of common mutations were: M694V (n = 1529, 44.5%), M680I (n = 423, 12.3%), V726A (n = 315, 9.2%), E148Q (n = 214, 1%), and M694I (n = 12, <1%). In this large-scale multicenter study, we provided information about the frequencies of common MEFV gene mutations obtained from adult Turkish FMF patients. Nearly half of the patients were carrying at least one M694V mutations in their alleles.

Sections du résumé

Background/aim
The distribution of Mediterranean fever (MEFV) gene mutations in Turkish familial Mediterranean fever (FMF) patients varies according to geographic area of Turkey. There is a need for highly representative data for Turkish FMF patients. The aim of our study was to investigate the distribution of the common MEFV mutations in Turkish FMF patients in a nationwide, multicenter study.
Materials and methods
Data of the 2246 FMF patients, from 15 adult rheumatology clinics located in different parts of the country, were evaluated retrospectively. The following mutations have been tested in all patients: M694V, M680I, M694I, V726A, and E148Q.
Results
There were 1719 FMF patients with available genetic testing. According to the genotyping, homozygous M694V, present in 413 patients (24%), was the most common mutation . One hundred and fifty-four (9%) of patients had no detectable mutations. Allele frequencies of common mutations were: M694V (n = 1529, 44.5%), M680I (n = 423, 12.3%), V726A (n = 315, 9.2%), E148Q (n = 214, 1%), and M694I (n = 12, <1%).
Conclusion
In this large-scale multicenter study, we provided information about the frequencies of common MEFV gene mutations obtained from adult Turkish FMF patients. Nearly half of the patients were carrying at least one M694V mutations in their alleles.

Identifiants

pubmed: 30887796
doi: 10.3906/sag-1809-100
pmc: PMC7018361
doi:

Substances chimiques

Cytoskeletal Proteins 0
MEFV protein, human 0
Pyrin 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

472-477

Références

Rheumatol Int. 2018 Jan;38(1):67-74
pubmed: 28828621
Gene. 2015 Sep 1;568(2):170-5
pubmed: 26003477
Open Rheumatol J. 2010 Jan 29;4:1-6
pubmed: 20177433
Hum Mutat. 2000 Jan;15(1):118-9
pubmed: 10612841
Medicine (Baltimore). 2005 Jan;84(1):1-11
pubmed: 15643295
Rheumatol Int. 2016 Jan;36(1):25-31
pubmed: 26215181
Mol Biol Rep. 2010 Jan;37(1):93-8
pubmed: 19449169
Mol Biol Rep. 2014;41(4):2601-7
pubmed: 24469716
Ann Rheum Dis. 2005 Jul;64(7):1009-14
pubmed: 15958759
Orphanet J Rare Dis. 2015 Mar 25;10:34
pubmed: 25887307
J Genet. 2015 Dec;94(4):629-35
pubmed: 26690517
Arthritis Rheum. 2009 Jun;60(6):1862-6
pubmed: 19479871
Eur J Hum Genet. 2001 Jul;9(7):473-83
pubmed: 11464238
Clin Rheumatol. 2008 Jun;27(6):729-32
pubmed: 18000697
Eur J Hum Genet. 2001 Jul;9(7):553-5
pubmed: 11464248
Rheumatol Int. 2009 Sep;29(11):1307-9
pubmed: 19152093
Gene. 2015 May 10;562(1):128-31
pubmed: 25703702
Mol Biol Rep. 2011 Nov;38(8):5065-9
pubmed: 21153919
Clin Exp Rheumatol. 2005 May-Jun;23(3):357-63
pubmed: 15971424
Gene. 2014 Aug 10;546(2):195-9
pubmed: 24929125
Arthritis Rheum. 2009 Jun;60(6):1851-61
pubmed: 19479870
Rheumatology (Oxford). 2014 Apr;53(4):741-5
pubmed: 24369413
Eur J Rheumatol. 2014 Mar;1(1):21-33
pubmed: 27708867
Mol Biol Rep. 2014 Mar;41(3):1419-26
pubmed: 24381109
Scand J Rheumatol. 1998;27(2):92-7
pubmed: 9572633
Genet Mol Res. 2012 May 07;11(2):1185-94
pubmed: 22614345
Arthritis Rheum. 1997 Oct;40(10):1879-85
pubmed: 9336425
Rheumatol Int. 2014 Feb;34(2):207-12
pubmed: 24071932

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH